RxDoctor Payments DataLook up a doctor →

Jaimin Patel, DO

Allergy · Henrico, VANPI 1992239701

Payments from drug & device makers

$14,000in general payments, 2019–2025

Across 444 payments — averaging $31.53 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$3K
  • GSK$2K
  • Regeneron Healthcare Solutions, Inc.$951
  • Sanofi$864
  • Amgen$779
  • CSL Behring$646
  • plus $6K from 37 others

General payments by program year

19
20
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AstraZeneca64$2,816
GSK63$1,558
Regeneron Healthcare Solutions, Inc.27$951
Sanofi28$864
Amgen28$779
CSL Behring28$646
Novartis27$641
Genentech USA, Inc.25$575
ARS Pharmaceuticals Operations, Inc.19$503
Boehringer Ingelheim5$384
AbbVie4$367
Kaleo, Inc.16$304
Teva Pharmaceuticals USA, Inc.8$292
Takeda Pharmaceuticals U.S.A., Inc.12$269
Blueprint Medicines Corporation10$269
Pharming Healthcare, Inc.8$235
Optinose US, Inc.8$227
Biocryst US Sales Co., LLC8$200
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC2$200
Johnson & Johnson2$192
Grifols USA, LLC8$186
BETA Bionics, Inc.6$161
Alk-abello, Inc2$143
Daiichi Sankyo Inc.1$125
Sunovion Pharmaceuticals Inc.1$121
Pfizer6$110
Novo Nordisk1$107
Incyte Corporation4$101
E.r. Squibb & Sons, L.L.C.1$91
Sanofi-aventis U.S. LLC1$85
Dermavant Sciences, Inc.1$68
Rigel Pharmaceuticals, Inc.1$61
Organon3$51
Greer Laboratories, Inc.2$47
Azurity Pharmaceuticals, Inc.2$43
Lilly USA, LLC2$40
Phadia US Inc.2$35
Hikma Pharmaceuticals USA2$35
Aimmune Therapeutics, Inc.2$33
Eisai Inc.1$30
Ionis Pharmaceuticals, Inc.1$24
Ferring Pharmaceuticals Inc.1$18
Merck1$14

How this compares

$14,000 in reported general payments places this provider in the 75th percentile of 26 allergy providers in Virginia.

See all allergy providers in Virginia →

Medicare billing

Part B allowed, 2024
$131,576
Medicare patients
176
Services billed
12,304

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other allergy in Henrico

See the full list for Virginia →

Where these figures come from

Is this you, or does something look wrong? →